HCAT Quote, Financials, Valuation and Earnings

Amedisys has a net margin of -25.97% compared to Health Catalyst's net margin of -3.41%. Health Catalyst's return on equity of -19.29% beat Amedisys's return on equity of 3.71%.

Health Catalyst has a consensus price target of $8.45, signalling upside risk potential of 115.13%. On the other hand Amedisys has an analysts' consensus of $96.86 which suggests that it could grow by 5.84%. Given that Health Catalyst has higher upside potential than Amedisys, analysts believe Health Catalyst is more attractive than Amedisys.

Health Catalyst has a beta of 1.435, which suggesting that the stock is 43.508% more volatile than S&P 500. In comparison Amedisys has a beta of 0.890, suggesting its less volatile than the S&P 500 by 11.035%.

Health Catalyst has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Amedisys offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Health Catalyst pays -- of its earnings as a dividend. Amedisys pays out -- of its earnings as a dividend.

Health Catalyst quarterly revenues are $79.6M, which are smaller than Amedisys quarterly revenues of $598.1M. Health Catalyst's net income of -$20.7M is lower than Amedisys's net income of -$20.4M. Notably, Health Catalyst's price-to-earnings ratio is -- while Amedisys's PE ratio is 69.86x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Health Catalyst is 0.77x versus 1.29x for Amedisys. Usually stocks with elevated PS ratios are considered overvalued.

AMN Healthcare Services has a net margin of -25.97% compared to Health Catalyst's net margin of -25.53%. Health Catalyst's return on equity of -19.29% beat AMN Healthcare Services's return on equity of -17.67%.

Health Catalyst has a consensus price target of $8.45, signalling upside risk potential of 115.13%. On the other hand AMN Healthcare Services has an analysts' consensus of $38.75 which suggests that it could grow by 102.77%. Given that Health Catalyst has higher upside potential than AMN Healthcare Services, analysts believe Health Catalyst is more attractive than AMN Healthcare Services.

Health Catalyst has a beta of 1.435, which suggesting that the stock is 43.508% more volatile than S&P 500. In comparison AMN Healthcare Services has a beta of -0.025, suggesting its less volatile than the S&P 500 by 102.532%.

Health Catalyst has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. AMN Healthcare Services offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Health Catalyst pays -- of its earnings as a dividend. AMN Healthcare Services pays out -- of its earnings as a dividend.

Health Catalyst quarterly revenues are $79.6M, which are smaller than AMN Healthcare Services quarterly revenues of $734.7M. Health Catalyst's net income of -$20.7M is higher than AMN Healthcare Services's net income of -$187.5M. Notably, Health Catalyst's price-to-earnings ratio is -- while AMN Healthcare Services's PE ratio is 18.72x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Health Catalyst is 0.77x versus 0.24x for AMN Healthcare Services. Usually stocks with elevated PS ratios are considered overvalued.

Option Care Health has a net margin of -25.97% compared to Health Catalyst's net margin of 4.47%. Health Catalyst's return on equity of -19.29% beat Option Care Health's return on equity of 14.93%.

Health Catalyst has a consensus price target of $8.45, signalling upside risk potential of 115.13%. On the other hand Option Care Health has an analysts' consensus of $38.44 which suggests that it could grow by 21.85%. Given that Health Catalyst has higher upside potential than Option Care Health, analysts believe Health Catalyst is more attractive than Option Care Health.

Health Catalyst has a beta of 1.435, which suggesting that the stock is 43.508% more volatile than S&P 500. In comparison Option Care Health has a beta of 1.074, suggesting its more volatile than the S&P 500 by 7.353%.

Health Catalyst has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Option Care Health offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Health Catalyst pays -- of its earnings as a dividend. Option Care Health pays out -- of its earnings as a dividend.

Health Catalyst quarterly revenues are $79.6M, which are smaller than Option Care Health quarterly revenues of $1.3B. Health Catalyst's net income of -$20.7M is lower than Option Care Health's net income of $60.1M. Notably, Health Catalyst's price-to-earnings ratio is -- while Option Care Health's PE ratio is 25.86x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Health Catalyst is 0.77x versus 1.09x for Option Care Health. Usually stocks with elevated PS ratios are considered overvalued.

OptimizeRx has a net margin of -25.97% compared to Health Catalyst's net margin of -0.24%. Health Catalyst's return on equity of -19.29% beat OptimizeRx's return on equity of -16.71%.

Health Catalyst has a consensus price target of $8.45, signalling upside risk potential of 115.13%. On the other hand OptimizeRx has an analysts' consensus of $10.33 which suggests that it could grow by 27.1%. Given that Health Catalyst has higher upside potential than OptimizeRx, analysts believe Health Catalyst is more attractive than OptimizeRx.

Health Catalyst has a beta of 1.435, which suggesting that the stock is 43.508% more volatile than S&P 500. In comparison OptimizeRx has a beta of 1.179, suggesting its more volatile than the S&P 500 by 17.909%.

Health Catalyst has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. OptimizeRx offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Health Catalyst pays -- of its earnings as a dividend. OptimizeRx pays out -- of its earnings as a dividend.

Health Catalyst quarterly revenues are $79.6M, which are larger than OptimizeRx quarterly revenues of $32.3M. Health Catalyst's net income of -$20.7M is lower than OptimizeRx's net income of -$78K. Notably, Health Catalyst's price-to-earnings ratio is -- while OptimizeRx's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Health Catalyst is 0.77x versus 1.61x for OptimizeRx. Usually stocks with elevated PS ratios are considered overvalued.